Publicações

Supplementary Table S3 from Beneficial Effects of Mifepristone Treatment in Patients with Breast Cancer Selected by the Progesterone Receptor Isoform Ratio: Results from the Mipra Trial

AuthID
P-015-D0C

Author(s)

Elía, A

Saldain, L

Vanzulli, SI

Helguero, LA

Lamb, CA

Fabris, V

Pataccini, G

Martínez-Vazquez, P

Burruchaga, J

Caillet-Bois, I

[+4]·

Lovisi, S

Abascal, MF

Novaro, V

Sánchez, J

Muñoz, J

Belizán, JM

Abba, MC

Gass, H

Rojas, P

Lanari, C

View all authors

Tipo de Documento

Unpublished

Year published

2023

Publicado

Indexing

Crossref^®

Google Scholar^®

Metadata
Fontes

Publication Identifiers

DOI: 10.1158/1078-0432.22490258.v1

Export Publication Metadata

Lista Marked

Adicionar à lista Marked

Info

At this moment we don't have any links to full text documens.

All authors

Name Order	Nome	Name Order	Nome	Name Order	Nome
1	Elía, A;	2	Saldain, L;	3	Vanzulli, SI;
4	Helguero, LA;	5	Lamb, CA;	6	Fabris, V;
7	Pataccini, G;	8	Martínez-Vazquez, P;	9	Burruchaga, J;
10	Caillet-Bois, I;	11	Spengler, E;	12	Acosta Haab, G;
13	Liguori, M;	14	Castets, A;	15	Lovisi, S;
16	Abascal, MF;	17	Novaro, V;	18	Sánchez, J;
19	Muñoz, J;	20	Belizán, JM;	21	Abba, MC;
22	Gass, H;	23	Rojas, P;	24	Lanari, C;

Supplementary Table S3 from Beneficial Effects of Mifepristone Treatment in Patients with Breast Cancer Selected by the Progesterone Receptor Isoform Ratio: Results from the Mipra Trial

Links Úteis

Ajuda

Autenticação Federada (Clique na imagem)

Supplementary Table S3 from Beneficial Effects of Mifepristone Treatment in Patients with Breast Cancer Selected by the Progesterone Receptor Isoform Ratio: Results from the Mipra Trial

Links Úteis

Ajuda